BHLIF yields 18181.82% · PFE yields 6.13%● Live data
📍 BHLIF pulled ahead of the other in Year 1
Combined, BHLIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BHLIF + PFE for your $10,000?
Bradda Head Lithium Limited, through its subsidiaries, engages in the exploration, development, and mining of lithium mining projects in the United States. It holds 100% interests in Basin East located in central western Arizona, which covers an area of approximately 3.78 square kilometers (km2); Basin West consists of 65 placer mining and 72 lode claims that cover an area of approximately 6.02 km2 situated in central western Arizona; and Wikieup project comprises 120 federal placer mining claims and 225 lode claims, which covers an area of approximately 27.87 km2 located in the Mohave County, Arizona. The company also owns Wilson Salt Flat, a lithium brine project located in Nye County, Nevada; the Eureka lithium brine project covering an area of 11.8km2; and the San Domingo project consists of 68 BLM placer claims, which covers an area of approximately 13.5 km2 located in the Maricopa and Yavapai counties, Arizona. The company was formerly known as Bradda Head Holdings Limited and changed its name to Bradda Head Lithium Limited in September 2021. Bradda Head Lithium Limited is headquartered in Douglas, Isle of Man.
Full BHLIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.